<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the present study, we demonstrate the utility of a non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-forming T-cell line for the inducible gene transfer of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-related <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-inducing ligand (Apo2L/TRAIL), which has been shown to selectively induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in malignant but not in <z:mpath ids='MPATH_458'>normal</z:mpath> cells </plain></SENT>
<SENT sid="1" pm="."><plain>To generate T cells inducible for TRAIL expression, we stably transfected Jurkat cells with TRAIL in the context of the Tet-On system </plain></SENT>
<SENT sid="2" pm="."><plain>The switched on cells strongly expressed TRAIL <z:chebi fb="2" ids="33699">mRNA</z:chebi>, whose protein product was expressed on the cell surface </plain></SENT>
<SENT sid="3" pm="."><plain>Paracrine induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in human target <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells was solely found for membrane-bound TRAIL </plain></SENT>
<SENT sid="4" pm="."><plain>The Jurkat-TRAIL cells itself survived due to clonal selection of TRAIL-resistant cells </plain></SENT>
<SENT sid="5" pm="."><plain>Jurkat-TRAIL cells had an additive effect with cytotoxic drugs in vitro, since cell <z:hpo ids='HP_0011420'>death</z:hpo> was enhanced </plain></SENT>
<SENT sid="6" pm="."><plain>To elucidate the antitumoral activity of these Jurkat-TRAIL cells in vivo, we injected them intratumorally in xenografts of human Burkitt <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Switching on expression of TRAIL by adding <z:chebi fb="9" ids="27902">tetracycline</z:chebi> to the drinking water of the mice strongly reduced <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumour growth</z:e> by <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a caspase-dependent manner </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, non-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-forming T-cell lines offer a novel method for gene transfer and inducible expression of TRAIL in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> therapy </plain></SENT>
</text></document>